Healthcare Supplies company Laxmi Dental announced Q3FY26 results Revenue: Rs 660.4 million against Rs 616.6 million during Q3FY25, change 7%. EBITDA: Rs 69.7 million against Rs 96.1 million during Q3FY25, change -27%. EBITDA Margin: 10.6% for Q3FY26. PBT: Rs 45.5 million against Rs 47.1 million during Q3FY25, change -3%. Rajesh Khakhar, Chairperson & Whole-Time Director, said: “In Q3FY26, the company delivered revenues of Rs 660 million as against Rs 61.7 crore in same period last year, recording a YoY growth of 7%. The performance is despite global macroeconomic and geopolitical challenges, underscoring the strength and resilience of our diversified portfolio. Gross profit margins witnessed minor improvement sequentially due to steady profitability in the laboratory and aligner business alongside a relatively lower contribution of scanner sales, which are low margin in nature. Scanner sales hold strategic importance for future growth across segments. During Q3, we had a full quarter impact of 150 bps on account of higher US tariffs. Additionally, we recorded a one-time exceptional provision of Rs 58 million towards gratuity past service liability under the new labour code. With US tariff normalization, positive development of EU FTA, multiple ongoing strategic initiatives, and consolidation in the domestic dental market, Laxmi Dental is well positioned to deliver resilient, industry-leading growth along with improved profitability going ahead.” Sameer Merchant, Managing Director & CEO, said: “For Q3FY26, our Dental lab business recorded a decent YoY growth of 10.4%, with international business delivering robust 25.5% YoY growth, while the domestic lab remained soft. Towards this, we have implemented innovative strategies in the quarter, and that has started showing positive results in the month of January 2026. Within the Aligner Solutions business, the competitive pricing pressures on Bizdent is getting normalized in the running quarter, Q4FY26, and we anticipate the situation to remain positive for the entire quarter. With the new strategic initiatives, we are seeing a strong recovery in our domestic dental lab and Bizdent businesses, and we expect both these segments to deliver robust YoY performance in Q4FY26. On the back of these positive trends, we expect to close FY26 with a healthy exit quarter and begin FY27 on a stronger footing. Over long-term, we remain committed towards promoting digital dentistry and spearheading this revolution for the entire dental industry in India on the back of our scanner solutions.” Result PDF